Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role Podcast
Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.
Related Resources
White Papers
This paper addresses the importance of the supply chain on overall health care costs and how transparent data can lead to a best practice sup
Case Studies
AHRMM is offering a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Case Studies
The following leading practice describes methods used to reduce Hospital Acquired Pressure Ulcers (HAPU).
Issue Brief
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013.
White Papers
This white paper explores the realities facing healthcare delivery, some of the new models being developed and what they could mean for the s
Advisory
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.